Jakub Neradil

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Tyrosine Kinase

Metastatic Renal Cell Carcinoma

Top Venues

International journal of molecular sciences

Nature communications

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Karolina Borankova, Maria Krchniakova, Lionel Y W Leck, Adela Kubistova, Jakub Neradil, Patric Jan Jansson, Michael D Hogarty, Jan Skoda
Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastoma. Cell death & disease 14 (11) (2023)
Polina Kameneva, Victoria I Melnikova, Maria Eleni Kastriti, Anastasia I Kurtova, Emil Kryukov, Aliia Murtazina, Louis Faure, Irina Poverennaya, Artem V Artemov, Tatiana S Kalinina, Nikita V Kudryashov, Michael Bader, Jan Skoda, Petr Chlapek, Lucie Curylova, Lukas Sourada, Jakub Neradil, Markéta Tesařová, Massimo Pasqualetti, Patricia Gaspar, Vasily D Yakushov, Boris I Sheftel, Tomas Zikmund, Josef Kaiser, Kaj Fried, Natalia Alenina, Elena E Voronezhskaya, Igor Adameyko
Serotonin limits generation of chromaffin cells during adrenal organ development. Nature communications 13 (1) (2022)
Silvia Paukovcekova, Maria Krchniakova, Petr Chlapek, Jakub Neradil, Jan Skoda, Renata Veselska
Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors. International journal of molecular sciences 23 (15) (2022)
Peter Macsek, Jan Skoda, Maria Krchniakova, Jakub Neradil, Renata Veselska
Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma. International journal of molecular sciences 23 (1) (2021)
Michal Mahdal, Jakub Neradil, Peter Mudry, Silvia Paukovcekova, Iva Staniczkova Zambo, Jiří Urban, Peter Macsek, Lukas Pazourek, Tomas Tomas, Renata Veselska
New Target for Precision Medicine Treatment of Giant-Cell Tumor of Bone: Sunitinib Is Effective in the Treatment of Neoplastic Stromal Cells with Activated PDGFRβ Signaling. Cancers 13 (14) (2021)
Maria Krchniakova, Jan Skoda, Jakub Neradil, Petr Chlapek, Renata Veselska
Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration. International journal of molecular sciences 21 (9) (2020)
Silvia Paukovcekova, Jan Skoda, Jakub Neradil, Erika Mikulenkova, Petr Chlapek, Jaroslav Sterba, Des R Richardson, Renata Veselska
Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms. Cancers 12 (12) (2020)